Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 6e-05 | 1 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -5.8e-05 | 1 |